在冠状动脉疾病的发病过程中对分子网络的多奥米洞察力
Qinghua Fang1, Hongdan Fan2, Qiaoqiao Li1
1Department of Cardiology The Second Affiliated Hospital of Chongqing Medical University Chongqing China.
Journal of the American Heart Association
|March 26, 2025
概括
这项研究确定了Transgelin 2 (TAGLN2),Apolipoprotein B (APOB) 和依赖葡萄糖的胰岛素型多 (GIP) 作为与冠状动脉疾病 (CAD) 风险相关的关键基因,提供了新的治疗点.
科学领域:
- 遗传学和基因组学 在
- 心血管疾病研究研究
- 分子生物学分子生物学
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了冠状动脉疾病 (CAD) 的众多位点.
- 然而,潜在的致病基因和CAD的有效疗法仍然难以捉摸.
- 了解CAD的遗传基础对于开发向治疗至关重要.
研究的目的:
- 确定与冠状动脉疾病 (CAD) 风险相关的新型因果基因.
- 整合多omics数据,以全面了解CAD分子机制.
- 探索基于遗传关联的CAD的潜在治疗点.
主要方法:
- 综合多omics数据,包括DNA甲基化,基因表达和蛋白质水平.
- 采用了基于总结数据的门德尔随机化和局部化分析.
- 利用单细胞RNA测序来检查CAD患者冠状动脉中的差异性基因表达.
主要成果:
- 转基因2 (TAGLN2),阿波利波蛋白B (APOB) 和依赖葡萄糖的胰岛素型多 (GIP) 被确定与CAD风险密切相关.
- TAGLN2显示了最重要的关联,观察到不同的监管机制.
- APOB和GIP与CAD风险有关,而DHX58和SWAP70与降低风险有关.
结论:
- 多omics数据证实TAGLN2,APOB,GIP,DHX58和SWAP70与CAD风险的关联.
- 这项研究为CAD的分子机制提供了新的见解.
- 整合多omics数据可以揭示传统GWAS错过的因果关系.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.2K
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.1K
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:30Coronary Artery Disease III: Clinical Manifestations
620
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495